The Ned team have been busy over the past few months, designing a fresh protocol for the app’s first clinical trial. Lead by PhD candidate, Quynh Pham and supported by eHI Lead, Dr. Joseph Cafazzo and Urologic Oncologist, Dr. Andrew Feifer, the trial seeks to gain a better understanding of how Ned (No Evident Disease) is adopted and accepted by patients, care givers and clinicians.
The trial itself, starting this month, breaks away from traditional methods of researching the general question, “does Ned work?” Rather, the trial’s focus has much more depth and seeks to explore “how or why does Ned work or not work, for whom, to what extent, in what respects, in what circumstances, and over what duration?” A mixed-methods embedded single-case study with a nested within-group pre-post comparison of health outcomes, allows the team to address this question in a meaningful way.
Considering that a mobile application’s success is often rated on user experience, the trial has been designed with full importance placed on the prostate cancer survivor. The research process has been completely digitized, allowing the individual to be in control and have a certain sense of ownership. Designers were recruited to make the study surveys as accessible and attractive as possible. Each element was finely reviewed, even down to the team holding a mock play, where the process of onboarding a patient into the Ned trial was acted out. All efforts performed were to ultimately support the entire journey the patient takes from the moment they get into the Ned trial, all the way through to the last time they choose to use the app.
“I’m not a clinician so the Ned patients aren’t my actual patients. But as a researcher, I feel like it’s up to me to make sure patients feel empowered as participants in my clinical trial. This philosophy has really led our decision to use a study design and methods that best meet the needs of patients.” – Quynh Pham
You can read the full protocol article via JMIR Publications here: